Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis Psychedelics

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by Leafs4Lifeon Nov 29, 2017 2:35pm

86 Views

Post# 27056668

RE:Marijuana Sector

May not need to wait until 2018. If their initial sales numbers from November surprise to the upside it could be a catalyst for hte stock, and we should be getting sales data in the second week of December. Merry f*king Christmas, gents.

JD2016 wrote: Is down today. The downside of this stock is limited but upside significant. When 2018 rolls around we we see great ROI. Accumulate at these prices.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal